hydrogen sulfide has been researched along with memantine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Hanaoka, K; Ichinose, F; Liu, J; Marutani, E; Nagano, T; Sakaguchi, M; Sasakura, K; Xian, M | 1 |
| Arai, K; Atochin, DN; Ichinose, F; Khatri, A; Kida, K; Kosugi, S; Marutani, E; Nguyen, R; Tokuda, K; Van Leyen, K | 1 |
| Bellusci, L; Calderone, V; Chiellini, G; Citi, V; Daniele, S; Martini, C; Pietrobono, D; Rapposelli, S; Sestito, S | 1 |
3 other study(ies) available for hydrogen sulfide and memantine
| Article | Year |
|---|---|
Cytoprotective effects of hydrogen sulfide-releasing
Topics: | 2014 |
A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death.
Topics: Animals; Brain Injuries; Brain Ischemia; Cell Death; Cell Line, Tumor; Cells, Cultured; Drug Design; Excitatory Amino Acid Antagonists; Glucose; Glutathione; Humans; Hydrogen Sulfide; Ischemia; Male; Memantine; Mice; Mice, Inbred C57BL; Models, Chemical; Neurons; Oxygen; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury | 2012 |
Memantine prodrug as a new agent for Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Autophagy; Cell Line; Humans; Hydrogen Sulfide; Inflammation; Memantine; Microglia; Neurons; Neuroprotective Agents; Primary Cell Culture; Prodrugs; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2019 |